Effects of acetylsalicylic acid on parameters related to peroxisome proliferation in mouse liver. Biochem Pharmacol 47:2213–2219.
Castillo J, Rama R, Da ́valos A. 2000. Nitric oxide-related brain damage in
acute ischemic stroke. Stroke 31:852– 857.
De Cristobal J, Ca ́rdenas A, Lizasoain I, Leza JC, Ferna ́ndez-Tome ́ P,
Lorenzo P, Moro MA. 2002. Inhibition of glutamate release via recovery
of ATP levels accounts for a neuroprotective effect of acetylsalicylic acid
in rat cortical neurons exposed to oxygen-glucose deprivation. Stroke
33:261–267.
De Gaetano G, Cerletti C, Dejana E, Lattini R. 1985. Pharmacology of
platelet inhibition in humans: implications of the salicylate-acetylsalicylic
acid interaction. Circulation 72:1185–1193.
De La Cruz JP, Blanco E, Sa ́nchez De La Cuesta F. 2000a. Effect of
dipyridamole and acetylsalicylic acid on the platelet-neutrophil interaction
via the nitric oxide pathway. Eur J Pharmacol 397:35– 41.
De La Cruz JP, Carrasco T, Ortega G, Sa ́nchez De La Cuesta F. 1992.
Inhibition of ferrous-induced lipid peroxidation by pyrimido-pyrimidine
derivatives in human liver membranes. Lipids 27:192–194.
De La Cruz JP, Guerrero A, Gonzalez-Correa JA, Marquez E, Nacle I,
Sa ́nchez De La Cuesta F. 2002a. Differences in the effect of two preparations of extended-release aspirin (75 mg) on platelet aggregation, prostanoids and nitric oxide production in humans. Eur J Clin Pharmacol
57:775–780.
De La Cruz JP, Guerrero A, Gonzalez-Correa JA, Marquez E, Martos F,
Sa ́nchez De La Cuesta F. 2003. Effects of 150 mg extended-release aspirin
on prostanoid and nitric oxide production in healthy volunteers. Fundam
Clin Pharmacol 17:363–372.
De La Cruz JP, Guerrero A, Paniego MJ, Arranz I, Moreno A, Sa ́nchez De
La Cuesta F. 2002b. Effect of acetylsalicylic acid on prostanoids and nitric
oxide production in streptozotocin-diabetic rats with ischemic retinopathy. Naunyn Schmiedebergs Arch Pharmacol 365:96 –101.
De la Cruz JP, Pav ́ıa J, Gonza ́lez-Correa JA, Ortiz P, Sa ́nchez De La Cuesta
F. 2000b. Effects of chronic administration of S-adenosyl-L-methionine
on brain oxidative stress in rats. Naunyn Schmiedebergs Arch Pharmacol
361:47–52.
De La Cruz JP, Villalobos MA, Cuerda MA, Guerrero A, Sa ́nchez De La
Cuesta F. 2002c. Protective effect of S-adenosyl-L-methionine in rat brain
slices exposed to reoxygenation after oxygen-glucose deprivation. Neurosci Lett 318:103–107.
De la Cruz JP, Villalobos MA, Seden~ o G, Sa ́nchez De La Cuesta F. 1998.
Effect of propofol on oxidative stress in an in vitro model of hypoxiareoxygenation in the rat brain. Brain Res 800:136 –144.
Endoh T, Tang Q, Denda A, Noguchi O, Kobayashi E, Tamura K,
Horiguchi K, Ogasawara H, Tsujiuchi T, Nakae D, Sugimura M, Konishi
Y. 1996. Inhibition by acetylsalicylic acid, a cyclo-oxygenase inhibitor,
and p-bromophenacylbromide, a phospholipase A inhibitor, of both
2

cirrhosis and enzyme-altered nodules caused by a choline-deficient,
L-amino acid-deficient diet in rats. Carcinogenesis 17:467– 475.
Flohe ́ L, Gunzler WA. 1985. Assays of glutathione peroxidase. Methods
Enzymol 105:114 –121.
Forman LJ, Liu P, Nagele RG, Yin K, Wong PY. 1998. Augmentation of
nitric oxide, superoxide, and peroxynitrite production during cerebral
ischemia and reperfusion in the rat. Neurochem Res 23:141–148.
Ga ́lvez J, De la Cruz JP, Zarzuelo A, Sa ́nchez-Medina F, Jime ́nez J, Sa ́nchez
De La Cuesta F. 1994. Oral administration of quercitrin modifies intestinal oxidative status in rats. Gen Pharmacol 25:1237–1243.
Grilli M, Pizzi M, Memo M, Spano P. 1996. Neuroprotection by acetylsalicylic acid and sodium salicylate through blockade of NF-kappa B
activation. Science 274:1383–1385.
Grotta JC, Lemak NA, Gary H, Fields WS, Vital D. 1985. Does platelet
antiaggregant therapy lessen the severity of stroke? Neurology 35:632–
636.
